PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26867799-0	2016	beta-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1.	beta-elemene	0-12	solute carrier family 31, member 1	Mus musculus	119-139	
26867799-4	2016	Western blot and laser scanning confocal microscopy studies indicated that beta-elemene enhanced the sensitivity of HCC cells to oxaliplatin by upregulating copper transporter 1 (CTR1), a major controller of intracellular platinum accumulation.	beta-elemene	75-87	solute carrier family 31, member 1	Mus musculus	157-177	
26867799-4	2016	Western blot and laser scanning confocal microscopy studies indicated that beta-elemene enhanced the sensitivity of HCC cells to oxaliplatin by upregulating copper transporter 1 (CTR1), a major controller of intracellular platinum accumulation.	beta-elemene	75-87	solute carrier family 31, member 1	Mus musculus	179-183	
26867799-6	2016	Notably, CTR1 protein expression in xenograft HCC was upregulated in mice who received beta-elemene treatment.	beta-elemene	87-99	solute carrier family 31, member 1	Mus musculus	9-13	
26867799-7	2016	Taken together, our findings show that beta-elemene can block the reduction of CTR1 resulting from oxaliplatin treatment, and therefore has a synergistic anti-HCC effect with oxaliplatin by enhancing cellular uptake of oxaliplatin.	beta-elemene	39-51	solute carrier family 31, member 1	Mus musculus	79-83